First Foundation Advisors’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.6M | Sell |
3,053
-50
| -2% | -$26.3K | 0.06% | 153 |
|
|
2025
Q1 | $1.97M | Buy |
3,103
+4
| +0.1% | +$2.54K | 0.08% | 127 |
|
|
2024
Q4 | $2.21M | Sell |
3,099
-10
| -0.3% | -$7.12K | 0.08% | 117 |
|
|
2024
Q3 | $3.27M | Hold |
3,109
| – | – | 0.12% | 103 |
|
|
2024
Q2 | $3.27M | Hold |
3,109
| – | – | 0.12% | 92 |
|
|
2024
Q1 | $2.99M | Buy |
3,109
+50
| +2% | +$48.1K | 0.12% | 94 |
|
|
2023
Q4 | $2.69M | Sell |
3,059
-169
| -5% | -$148K | 0.12% | 98 |
|
|
2023
Q3 | $2.66M | Sell |
3,228
-1
| -0% | -$823 | 0.12% | 102 |
|
|
2023
Q2 | $2.32M | Sell |
3,229
-138
| -4% | -$99.2K | 0.1% | 123 |
|
|
2023
Q1 | $2.77M | Buy |
3,367
+66
| +2% | +$54.2K | 0.13% | 108 |
|
|
2022
Q4 | $2.38M | Buy |
+3,301
| New | +$2.38M | 0.11% | 113 |
|
|
2021
Q4 | – | Sell |
-2,422
| Closed | -$1.47M | – | 462 |
|
|
2021
Q3 | $1.47M | Sell |
2,422
-377
| -13% | -$228K | 0.05% | 161 |
|
|
2021
Q2 | $1.56M | Buy |
2,799
+52
| +2% | +$29.1K | 0.06% | 164 |
|
|
2021
Q1 | $1.3M | Buy |
2,747
+1,590
| +137% | +$752K | 0.06% | 174 |
|
|
2020
Q4 | $559K | Buy |
+1,157
| New | +$559K | 0.02% | 251 |
|